GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Vical Incorporated (VICL) [hlAlert]

Rating:
Buy VICL
down 87.12 %

Vical Incorporated (VICL) rated Buy with price target $9 by Global Hunter Securities

Posted on: Thursday,  Dec 1, 2011  9:25 AM ET by Global Hunter Securities

Global Hunter Securities rated Buy Vical Incorporated (NASDAQ: VICL) on 12/01/2011, when the stock price was $4.35. Since
then, Vical Incorporated has lost 87.13% as of 01/07/2016's recent price of $0.56.
If you would have followed this Global Hunter Securities's recommendation on VICL, you would have lost 87.12% of your investment in 1498 days.

Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA vaccines for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The company is developing certain infectious disease vaccines and cancer therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product pipeline and address significant unmet medical needs.

Global Hunter Securities uses a disciplined quantitative and qualitative approach, our analysts are focused on covering small-cap companies with unique value and above average growth, primarily in the following sectors: Consumer, Energy, Healthcare, Industrial, Services and Technology. Additionally, Global Hunter Securities has analysts specifically focused on Special Situations and International opportunities. Global Hunter Securities' analysts maintain strong relationships and ongoing dialogue with management teams and industry professionals to ensure propitious access to information.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/1/2011 9:25 AM Buy
None
4.35 9.00
as of 12/30/2011
1 Week down  -1.78 %
1 Month up  1.37 %
3 Months   
1 YTD up  1.37 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy